Free Trial

Mustang Bio (MBIO) Insider Trading & Ownership

Mustang Bio logo
$0.21 0.00 (0.00%)
(As of 11/22/2024 ET)

Mustang Bio (NASDAQ:MBIO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.84%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$3,696.30
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$7,987.95
Get MBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Mustang Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MBIO Insider Buying and Selling by Quarter

Mustang Bio Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/18/2023Manuel Md LitchmanDirectorBuy333$11.10$3,696.30  
12/14/2021Brian AchenbachSVPSell291$27.45$7,987.95  
(Data available from 1/1/2013 forward)

MBIO Insider Trading Activity - Frequently Asked Questions

The list of insiders at Mustang Bio includes Brian Achenbach, and Manuel Md Litchman. Learn more on insiders at MBIO.

0.84% of Mustang Bio stock is owned by insiders. Learn more on MBIO's insider holdings.

The following insider purchased MBIO shares in the last 24 months: Manuel Md Litchman ($3,696.30).

Insiders have purchased a total of 333 MBIO shares in the last 24 months for a total of $3,696.30 bought.

Mustang Bio Key Executives

  • Mr. Michael S. Weiss Esq. (Age 58)
    Executive Chairman
    Compensation: $60k
  • Dr. Manuel Litchman M.D. (Age 70)
    President, CEO & Director
    Compensation: $480.79k
  • Mr. James B. Murphy (Age 67)
    Interim Chief Financial Officer
  • Mr. Peter Carney (Age 37)
    Controller & Interim Chief Accounting Officer
  • Mr. Matthew Wein J.D.
    VP & General Counsel
  • Ms. Debra Manning SPHR
    Senior VP & Head of Human Resources
  • Ms. Lynn E. Bayless M.S.
    VP & Head of Regulatory Affairs
  • Dr. Bruce Dezube M.D.
    Senior VP & Head of Clinical Development
  • Mr. Greg Furrow M.S.
    Chief Quality Officer
  • Mr. Richard Bodmer M.S.
    Head of CMC Development


This page (NASDAQ:MBIO) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners